Icubate

Description

• Symptoms are often shared, but diseases are personal. Personalized medicine should start with personalized diagnosis. iCubate® is developing and marketing enabling technologies and products for personalized diagnostics of infectious diseases and various research applications.Molecular diagnostics involves multiple experimental steps, methods and instruments. Providing an integrated solution requires innovative thinking and deep understanding of the marketplace. iCubate® is offering a multiplexed, automated and closed system, the iCubate® platform, and making the bench-­side technologies available to the bedside of patients.iCubate® is a privately-held, molecular diagnostic company with a patented multiplex polymerase chain reaction (mPCR) technology; an integrated platform for automated sample preparation, amplification and detection; and a product line for infectious disease diagnostics and research applications.Currently available for Research-Use applications only, the iCubate® technology creates a single-step multiplex PCR MDx Platform: -True single-step, walk away PCR MDx platform -Extraction, amplification, high density multiplexing, detection and automation -Multiplexing at amplification and not detection, providing superior accuracy
• 

  Headquarters:601 Genome Way Suite 3005, Huntsville, Alabama, United States

  More
• 

  Phone Number: +1 256-327-0483

• 

  Website: https://www.icubate.com

• 

  Employees:14

• 

  Revenue:$10 - 50M

• 

  Legal Name:Icubate

• Icubate's Social Media

  
• Is this data correct?

• |  NAICS Code: 541714  |

  Show More